Stage Iiib Breast Cancer
📧 Sign up to get email alerts when something new happens for Stage Iiib Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-10-23Clinical Trial Update: Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer [Phase 1]
A Phase 1 trial evaluated MK-2206 in combination with lapatinib in patients with advanced or metastatic breast cancer, including HER2-positi…
-
CLINICAL_TRIALS trial_result · 2014-10-06Clinical Trial Update: Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer [Phase 2]
Phase 2 trial evaluating capecitabine and lapatinib with or without cixutumumab in previously treated HER2-positive Stage IIIB-IV breast can…
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery [Phase 2]
This is a Phase 2 trial update of saracatinib for metastatic or unresectable locally advanced breast cancer. It includes estrogen receptor-n…
-
CLINICAL_TRIALS withdrawal · 2013-07-10Clinical Trial Update: Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer [Phase 2]
A Phase 2 trial evaluating neoadjuvant and adjuvant exemestane for postmenopausal women with locally advanced hormone receptor-positive brea…
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating the three-drug combination of tipifarnib, doxorubicin, and cyclophosphamide in women with locally advanced breast c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating a rebeccamycin analogue for Stage IIIB or Stage IV breast cancer has completed.